Constitutive activation of FLT3 kinase through internal tandem duplications (FLT3-ITD) or missense mutations in the FLT3 tyrosine kinase domain109 has been observed in approximately 30% of patients with acute myeloid leukemia (AML) and a normal karyotype109,110. Here, FLT3 is linked to acute myeloid leukemia.